Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream Apr 16, 2025 07:00AM
Evofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTO Feb 13, 2025 09:16AM
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 Nov 14, 2024 04:36PM
Evofem Secures Investor Support for Proposed Merger through Voting Agreements Nov 6, 2024 08:00AM
Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem Oct 28, 2024 08:15AM


Oct 8, 2024 08:15AM Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem
Sep 24, 2024 08:15AM Evofem Biosciences (EVFM) Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt (ADTX)
Sep 24, 2024 08:15AM Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt
Sep 20, 2024 08:15AM Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025
Sep 9, 2024 08:15AM Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024
Aug 20, 2024 08:17AM Evofem Biosciences (EVFM) Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution
Aug 20, 2024 08:17AM Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution
Aug 14, 2024 07:00AM Evofem Biosciences Announces Financial Results for the Second Quarter of 2024
Jul 23, 2024 08:47AM Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1
Jul 26, 2022 08:47AM Evofem's House Rules Campaign Featuring Annie Murphy Receives Significant Industry Recognition
Oct 20, 2021 08:00AM "House Rules" Delivers Strong Initial Results and Drives Phexxi Growth
Sep 9, 2021 08:00AM Emmy® Award Winner Annie Murphy Partners with Evofem Biosciences to Talk Sex, Contraception, and Why She Chose Phexxi®
Feb 16, 2021 08:00AM Evofem Biosciences Launches U.S. Direct-to-Consumer Campaign to Accelerate Awareness of Phexxi®, A Non-Hormonal Birth Control Option for Women
Sep 25, 2019 04:00AM Microbiotica Appoints Thomas Lynch as Independent Non-Executive Chairman